Sunrest Lifescience Board of Directors

Get the latest insights into the leadership at Sunrest Lifescience. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Ms. Juhi Sawajani Chairman(NonExe.&Ind.Director)
Mr. Nikhilkumar Yashvntlal Thakkar Managing Director
Mr. Amitbhai Shambhulal Thakkar Whole Time Director
Mr. Bharatkumar Vardhilal Thakkar Director
Mr. Bhagyesh Kiritbhai Parekh Non Executive Director
Ms. Avani Ashwinkumar Shah Ind. Non-Executive Director

Sunrest Lifescience Share price

SUNREST

49.2

0.00 (0.00%)
NSE
BSE
Last updated on 2 Sep, 2025 | 09:00 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

44.60

52 Week High

75.00

The current prices are delayed, login to your account for live prices

Sunrest Lifescience FAQs

The board at Sunrest Lifescience consists of experienced professionals, including Ms. Juhi Sawajani , Mr. Nikhilkumar Yashvntlal Thakkar , and others, overseeing the company’s strategic and corporate governance.

Directors at Sunrest Lifescience are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Ms. Juhi Sawajani is the current chairman at Sunrest Lifescience.

Executive directors at Sunrest Lifescience are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Sunrest Lifescience adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Sunrest Lifescience, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.